Skip to main content
. 2022 Jan 30;10(2):223. doi: 10.3390/vaccines10020223

Table 3.

Associations of the reported COVID-19 vaccine side-effects with the participants’ background characteristics (n = 437).

Characteristic Reported Side-Effects OR (95% CI) p
Yes (n = 250) No (n = 187)
Age group (years)
20–30 (n = 169) 94 (55.6) 75 (44.4) 1
31–40 (n = 202) 115 (56.9) 87 (43.1) 1.06 (0.70, 1.60) 0.801
41–50 (n = 50) 29 (58.0) 21 (42.0) 1.10 (0.58, 2.09) 0.766
>50 (n = 16) 12 (75.0) 4 (25.0) 2.39 (0.74, 7.72) 0.134
Gender
Female (n = 283) 160 (56.5) 123 (43.5) 0.93 (0.62, 1.38) 0.701
Male (n = 154) 90 (58.4) 64 (41.6) 1
Nationality
Saudi (n = 190) 138 (73.8) 49 (26.2) 3.47 (2.30, 5.23) <0.001 *
Non-Saudi (n = 254) 112 (44.8) 138 (55.2) 1
Marital status
Married (n = 255) 145 (57.2) 105 (42.0) 1.08 (0.74, 1.58) 0.699
Single (n = 189) 105 (56.1) 82 (43.9) 1
Residence
Jazan (n = 378) 205 (54.2) 173 (45.8) 0.36 (0.15, 0.86) 0.017
Sabia (n = 29) 22 (75.9) 7 (24.1) 0.96 (0.29, 3.18) 0.924
Abu Arish (n = 30) 23 (76.7) 7 (23.3) 1
Occupation
Medical (n = 245) 125 (51.0) 120 (49.0) 0.56 (0.38, 0.82) 0.003 *
Nonmedical (n = 192) 125 (65.1) 67 (34.9) 1
Diagnosed previously with COVID-19
Yes (n = 55) 28 (50.9) 27 (49.1) 0.75 (0.43, 1.32) 0.313
No (n = 382) 222 (58.1) 160 (41.9) 1

OR, odds ratio; CI, confidence interval. Significant association (unadjusted p < 0.05). * Significant association (using the Bonferroni–Holm correction for multiple comparisons).